Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:693  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1Liver stiffness measurement for risk assessment of hepatocellular carcinoma
Akihisa Tatsumi,Shinya Maekawa,Mitsuaki Sato,Nobutoshi Komatsu,Mika Miura,Fumitake Amemiya,Yasuhiro Nakayama,Taisuke Inoue,Minoru Sakamoto,Nobuyuki Enomoto
Hepatology Research.2015;45(5)523
[DOI]
2New chemical constituents from the Piper betle Linn. (Piperaceae)
Akhtar Atiya,Barij Nayan Sinha,Uma Ranjan Lal
Natural Product Research.2018;32(9)1080
[DOI]
3Hepatitis C therapy: Looking toward interferon-sparing regimens
Trang H. Au,Christopher J. Destache,Renuga Vivekanandan
Journal of the American Pharmacists Association.2015;55(2)e72
[DOI]
4Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature
Catherine Atkin,Philip Earwaker,Arvind Pallan,Shishir Shetty,Pankaj Punia,Yuk Ting Ma
BMC Gastroenterology.2017;17(1)e72
[DOI]
5The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders
Asia Owais,Rama K. Mishra,Hiroaki Kiyokawa
Cancers.2020;12(8)2108
[DOI]
6Molecular basis of benzimidazole inhibitors to hepatitis C virus envelope glycoprotein
Reaz Uddin,Kevin M. Downard
Chemical Biology & Drug Design.2018;92(3)1638
[DOI]
7The Changing Face of Hepatocellular Carcinoma: Forecasting Prevalence of Nonalcoholic Steatohepatitis and Hepatitis C Cirrhosis
Osmanuddin Ahmed,Lisa Liu,Antony Gayed,Amanjit Baadh,Mikin Patel,Jordan Tasse,Ulku Turba,Bulent Arslan
Journal of Clinical and Experimental Hepatology.2019;9(1)50
[DOI]
8Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients
AM Attallah,M El-Far,MA Abdelrazek,MM Omran,AA Attallah,AA Elkhouly,HM Elkenawy,K Farid
British Journal of Biomedical Science.2017;74(4)170
[DOI]
9RETRACTED: miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA
Wenxian Cui,Yuanguo Li,Keqing Xu,Guijin Chen,Xiaoqun Lu,Qiuqin Duan,Zhirong Kang
Biochemical and Biophysical Research Communications.2016;479(4)901
[DOI]
10Identification of Indian sub-continent as hotspot for HCV genotype 3a origin by Bayesian evolutionary reconstruction
Manish Chandra Choudhary,Vidhya Natarajan,Priyanka Pandey,Ekta Gupta,Shvetank Sharma,Rachana Tripathi,M. Shesheer Kumar,Syed N. Kazim,Shiv K. Sarin
Infection, Genetics and Evolution.2014;28(4)87
[DOI]
11Space Occupying Lesions in the Liver
Manigandan Subramanyam Thyagarajan,Khalid Sharif
The Indian Journal of Pediatrics.2016;83(11)1291
[DOI]
12Microbial lipases and their industrial applications: a comprehensive review
Prem Chandra,Prem Enespa,Ranjan Singh,Pankaj Kumar Arora
Microbial Cell Factories.2020;19(1)1291
[DOI]
13The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs
Lianping Ti,María Eugenia Socías,Evan Wood,M-J Milloy,Ekaterina Nosova,Kora DeBeck,Thomas Kerr,Kanna Hayashi,Yury E. Khudyakov
PLOS ONE.2018;13(3)e0194162
[DOI]
14Reactive oxygen species dependent phosphorylation of the liver kinase B1/AMP activated protein kinase/ acetyl-CoA carboxylase signaling is critically involved in apoptotic effect of lambertianic acid in hepatocellular carcinoma cells
Arong Jeong,Ju-Ha Kim,Hyo-Jung Lee,Sung-Hoon Kim
Oncotarget.2017;8(41)70116
[DOI]
15Sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C infection: Impact of drug concentration on viral load decay
Victor Virlogeux,Laure Choupeaux,Pierre Pradat,Marianne Maynard,François Bailly,Caroline Scholtès,Marie-Claude Gagnieu,Fabien Zoulim
Digestive and Liver Disease.2016;48(11)1351
[DOI]
16Network-Based Study Reveals Potential Infection Pathways of Hepatitis-C Leading to Various Diseases
Anirban Mukhopadhyay,Ujjwal Maulik,Wenzhe Ho
PLoS ONE.2014;9(4)e94029
[DOI]
17Estimation of Copper and Iron Burden in Biological Samples of Various Stages of Hepatitis C and Liver Cirrhosis Patients
Salma Aslam Arain,Tasneem G Kazi,Hassan Imran Afridi,Farah Naz Talpur,Moina Akhtar Mughal,Faheem Shah,Sadaf Sadia Arain,Abdul Haleem Panhwar
Biological Trace Element Research.2014;160(2)197
[DOI]
18Microorganisms in the Treatment of Cancer: Advantages and Limitations
Klaudia Lukasiewicz,Marek Fol
Journal of Immunology Research.2018;2018(2)1
[DOI]
19The Role of Autophagy in Interferon/Ribavirin Responders and Non-Responders with Hepatitis C Virus Infection
Fahimeh Abbasi,Taravat Bamdad,Abdolkarim Ghadimi-Moghadam,Hamzeh Chubin,Marzieh Jamalidoust
Jundishapur Journal of Microbiology.2020;13(3)1
[DOI]
20The Role of Autophagy in Interferon/Ribavirin Responders and Non-Responders with Hepatitis C Virus Infection
Anupama Setia,Priyanka Ahuja
Jundishapur Journal of Microbiology.2018;13(3)293
[DOI]
21Significance of growth differentiation factor 15 in chronic HCV patients
Mohab H. Halim,Nour A. Abdulla,Abdelkarim Kamel,Nabila Abd El Maksoud,Halla M. Ragab
Journal of Genetic Engineering and Biotechnology.2017;15(2)403
[DOI]
22Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Phil McEwan,Samantha Webster,Thomas Ward,Michael Brenner,Anupama Kalsekar,Yong Yuan
Cost Effectiveness and Resource Allocation.2017;15(1)403
[DOI]
23Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Snezana Jovanovic-Cupic,Ana Bozovic,Milena Krajnovic,Nina Petrovic
Cost Effectiveness and Resource Allocation.2018;15(1)403
[DOI]
24Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2–5 February 2017
Rodolfo Sacco,Aurora Mirabile,Luca Giacomelli,Giampaolo Bresci,Simona Attardo,Giuseppe Cabibbo
Future Oncology.2017;13(15)1297
[DOI]
25Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4
Tarek Kamal Motawi,Olfat Gamil Shaker,Shohda Assem El-Maraghy,Mahmoud Ahmed Senousy,Chen-Hua Liu
PLOS ONE.2015;10(3)e0120794
[DOI]
26Hepatocellular Carcinoma: Etiology and Current and Future Drugs
Aastha Jindal,Anusha Thadi,Kunwar Shailubhai
Journal of Clinical and Experimental Hepatology.2019;9(2)221
[DOI]
27Review on chemogenomic approaches towards hepatitis C viral targets
Arthi Venkatesan,Febin Prabhu Dass J.
Journal of Cellular Biochemistry.2019;120(8)12167
[DOI]
28A 3D structural model and dynamics of hepatitis C virus NS3/4A protease (genotype 4a, strain ED43) suggest conformational instability of the catalytic triad: implications in catalysis and drug resistivity
Bradley Rimmert,Salwa Sabet,Edward Ackad,Mohammad S. Yousef
Journal of Biomolecular Structure and Dynamics.2014;32(6)950
[DOI]
29Genetic diversity of hepatitis C virus in Ethiopia
Gadissa Bedada Hundie,V. Stalin Raj,Daniel GebreMichael,Suzan D. Pas,Bart L. Haagmans,Jason Blackard
PLOS ONE.2017;12(6)e0179064
[DOI]
30Transcriptomic profiling of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma
Hongxia Fan,Qiaoge Zhang,Xiaopei Zhao,Ping Lv,Min Liu,Hua Tang
Oncotarget.2017;8(39)65421
[DOI]
31Prevalence of hepatitis C virus infection and its impact on the prognosis of head and neck cancer patients
Juliana de Brito Rangel,Luiz Claudio Santos Thuler,Jorge Francisco da Cunha Pinto
Oral Oncology.2018;87(39)138
[DOI]
32Direct-acting antivirals and interferon-based therapy on hepatocellular carcinoma risk in chronic hepatitis-C patients
Longteng Ma,Jiluo Liu,Wei Wang,Fan Yang,Ping Li,Shiliang Cai,Xinyu Zhou,Xi Chen,Xun Zhuang,Hongwei Zhang,Guangwen Cao
Future Oncology.2020;16(11)675
[DOI]
33miR-592/WSB1/HIF-1a axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth
Yan-Yan Jia,Jin-Yi Zhao,Bing-Ling Li,Kai Gao,Ying Song,Mei-You Liu,Xiao-Juan Yang,Yan Xue,Ai-Dong Wen,Lei Shi
Oncotarget.2016;7(23)35257
[DOI]
34A bibliometric analysis of the global research on sofosbuvir
Akram Hernández-Vásquez,Diego Rosselli
F1000Research.2017;6(23)1536
[DOI]
35Phosphorylated AKT expression in tumor-adjacent normal tissue is associated with poor prognosis in patients with hepatocellular carcinoma
Yao-Li Chen,Po-Ming Chen,Ying-Zi Ming,Ping-Yi Lin,Chih-Ping Chu,Pei-Yi Chu
Oncology Letters.2017;6(23)1536
[DOI]
36Association between Aflatoxin M1 and Liver Disease in HBV/HCV Infected Persons in Ghana
Clarrisa Afum,Lorene Cudjoe,Justin Hills,Raymond Hunt,Luz Padilla,Sarah Elmore,Abena Afriyie,Ohene Opare-Sem,Timothy Phillips,Pauline Jolly
International Journal of Environmental Research and Public Health.2016;13(4)377
[DOI]
37Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis
Saroj Nazareth,Nadine Leembruggen,Rhoda Tuma,Sook-Ling Chen,Samarth Rao,Nick Kontorinis,Wendy Cheng
International Journal of Nursing Practice.2016;22(4)3
[DOI]
38New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment
Maria A. Sorbera,Michelle L. Friedman,Rebecca Cope
Journal of Pharmacy Practice.2017;30(3)359
[DOI]
39Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus
Kim B Pedersen,Casey F Pulliam,Aarshvi Patel,Fabio Del Piero,Tatiane T N Watanabe,Umesh D Wankhade,Kartik Shankar,Chindo Hicks,Martin J Ronis
Carcinogenesis.2019;40(2)349
[DOI]
40Prevalence of Hepatitis C Virus Infection in Patients With Renal-Cell Carcinoma
Julio Cesar Albuquerque Rangel,Juliana de Brito Rangel,Luiz Claudio Santos Thuler,Jorge Francisco da Cunha Pinto
Clinical Genitourinary Cancer.2020;40(2)349
[DOI]
41Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation
Anna Maria Mileo,Stefano Mattarocci,Paola Matarrese,Simona Anticoli,Claudia Abbruzzese,Stefania Catone,Rodolfo Sacco,Marco G. Paggi,Anna Ruggieri
Journal of Experimental & Clinical Cancer Research.2015;34(1)349
[DOI]
42Enhanced Artificial Bee Colony Algorithm for Liver Cancer Analysis
K. Lokanayaki,A. Malathi
Journal of Testing and Evaluation.2018;46(3)20160411
[DOI]
43Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection
Yasuhiro Matsue,Mikihiro Tsutsumi,Nobuhiko Hayashi,Takashi Saito,Mutsumi Tsuchishima,Nobuyuki Toshikuni,Tomiyasu Arisawa,Joseph George,Ratna B. Ray
PLOS ONE.2015;10(3)e0118744
[DOI]
44Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598
Weiwei Xue,Pingzu Jiao,Huanxiang Liu,Xiaojun Yao
Antiviral Research.2014;104(3)40
[DOI]
45TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors
Timothy T. Spear,Glenda G. Callender,Jeffrey J. Roszkowski,Kelly M. Moxley,Patricia E. Simms,Kendra C. Foley,David C. Murray,Gina M. Scurti,Mingli Li,Justin T. Thomas,Alexander Langerman,Elizabeth Garrett-Mayer,Yi Zhang,Michael I. Nishimura
Cancer Immunology, Immunotherapy.2016;65(3)293
[DOI]
46Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis
Karn Wijarnpreecha,Pitchaphon Nissaisorakarn,Suthanya Sornprom,Charat Thongprayoon,Natanong Thamcharoen,Kunlatida Maneenil,Alexander J Podboy,Wisit Cheungpasitporn
World Journal of Gastrointestinal Pathophysiology.2016;7(4)314
[DOI]
47Microarray analysis on the lncRNA expression profile in male hepatocelluar carcinoma patients with chronic hepatitis B virus infection
Jianjun Niu,Yong Lin,Pingguo Liu,Yiwen Yu,Chenghao Su,Xiaomin Wang
Oncotarget.2016;7(46)76169
[DOI]
48Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein
Ting-Chun Hung,Alagie Jassey,Ching-Hsuan Liu,Chien-Ju Lin,Chun-Ching Lin,Shu Hui Wong,Jonathan Y. Wang,Ming-Hong Yen,Liang-Tzung Lin
Phytomedicine.2019;53(46)62
[DOI]
49Hepatocellular Carcinoma and Viral Hepatitis in New York City
Miranda S. Moore,Elena Ivanina,Katherine Bornschlegel,Baozhen Qiao,Maria J. Schymura,Fabienne Laraque
Clinical Infectious Diseases.2016;63(12)1577
[DOI]
50Cancer in the Solomon Islands
Alexandra Martiniuk,Rooney Jagilli,Eileen Natuzzi,John Wesley Ilopitu,Meltus Oipata,Annie-Marie Christie,Jefferey Korini,Cassandra Vujovich-Dunn,William Yu
Cancer Epidemiology.2017;50(12)176
[DOI]
51Cytotoxicity of Naturally Occurring Isoquinoline Alkaloids of Different Structural Types
Jakub Chlebek,Ivo Doskocil,Daniela Hulcová,Katerina Breiterová,Marcela Šafratová,Radim Havelek,Klára Habartová,Anna Hošt'alková,Tereza Volštatová,Lucie Cahliková
Natural Product Communications.2016;11(6)1934578X1601100
[DOI]
52Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals
Ivan Schietroma,Giuseppe Corano Scheri,Claudia Pinacchio,Maura Statzu,Arnolfo Petruzziello,Vincenzo Vullo
The Open Virology Journal.2018;12(1)16
[DOI]
53Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients
Marwa K. Ibrahim,Hosny Salama,Mohamad Abd El Rahman,Reham M. Dawood,Noha G. Bader El Din,Heba F. Salem,Mohamed E.A. Abdelrahim,Dalia Omran,Moataza H. Omran,Khaled Helmi El-Wakeel,Tawfeek H. Abdelhafez,Ahmed Khedr,Mostafa K. El Awady
Journal of Interferon & Cytokine Research.2016;36(12)698
[DOI]
54Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis
Ikram Sghaier,Etienne Brochot,Besma Y. Loueslati,Wassim Y. Almawi
Reviews in Medical Virology.2019;29(2)e2033
[DOI]
55Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus
Abdel Hady A. Abdel Wahab,Medhat S. El-Halawany,Ahmad A. Emam,Ammar Elfiky,Zakaria Y. Abd Elmageed
Biomarkers.2016;29(2)1
[DOI]
56Long Non-Coding RNA SNHG6 as a Potential Biomarker for Hepatocellular Carcinoma
Maryam Tahmasebi Birgani,Mohammadreza Hajjari,Arman Shahrisa,Atefeh Khoshnevisan,Zahra Shoja,Paria Motahari,Baharak Farhangi
Pathology & Oncology Research.2018;24(2)329
[DOI]
57Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C
Aldona Kasprzak
World Journal of Gastroenterology.2015;21(13)3867
[DOI]
58In silico analysis of Hepatitis C virus (HCV) polyprotein domains and their comparison with other pathogens and allergens to gain insight on pathogenicity mechanisms
Seema Patel
Computational Biology and Chemistry.2016;65(13)91
[DOI]
59Retracted Article: Bioinformatic Analysis of Codon Usage and Phylogenetic Relationships in Different Genotypes of the Hepatitis C Virus
Mojtaba Mortazavi,Mohammad Zarenezhad,Seyed Moayed Alavian,Saeed Gholamzadeh,Abdorrasoul Malekpour,Mohammad Ghorbani,Masoud Torkzadeh Mahani,Safa Lotfi,Ali Fakhrzad
Hepatitis Monthly.2016;16(10)91
[DOI]
60DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
Loredana Cifaldi,Margherita Doria,Nicola Cotugno,Sonia Zicari,Caterina Cancrini,Paolo Palma,Paolo Rossi
International Journal of Molecular Sciences.2019;20(15)3715
[DOI]
61DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
Khursheed ul Islam,Jawed Iqbal
International Journal of Molecular Sciences.2019;20(15)233
[DOI]
62microRNAs: Key players in virus-associated hepatocellular carcinoma
Javid Sadri Nahand,Farah Bokharaei-Salim,Arash Salmaninejad,Abolfazl Nesaei,Fatemeh Mohajeri,Azadeh Moshtzan,Alireza Tabibzadeh,Mohammad Karimzadeh,Mohsen Moghoofei,Arezo Marjani,Shoeleh Yaghoubi,Hossein Keyvani
Journal of Cellular Physiology.2019;234(8)12188
[DOI]
63microRNAs: Key players in virus-associated hepatocellular carcinoma
Subhayan Das,Moumita Kundu,Bikash Chandra Jena,Mahitosh Mandal
Journal of Cellular Physiology.2020;234(8)607
[DOI]
64An Easy and Useful Noninvasive Score Based on a-1-acid Glycoprotein and C-Reactive Protein for Diagnosis of Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection
Mohamed M. Omran,Tarek M. Emran,Khaled Farid,Fathy M. Eltaweel,Mona A. Omar,Fagr B. Bazeed
Journal of Immunoassay and Immunochemistry.2016;37(3)273
[DOI]
65An Easy and Useful Noninvasive Score Based on a-1-acid Glycoprotein and C-Reactive Protein for Diagnosis of Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection
Costin Teodor Streba,Cristin Constantin Vere,Ion Rogoveanu,Nicu Dan Florescu
Journal of Immunoassay and Immunochemistry.2018;37(3)273
[DOI]
66When a road traffic accident leads to a skull metastasis from hepatocellular carcinoma: A unique case presentation
Safwan O. Alomari,Abdelwahab J. Aeshawi,Omar Jbarah,Amer A. Jaradat,Mohammed Z. Allouh
Interdisciplinary Neurosurgery.2020;21(3)100745
[DOI]
67Metastatic hepatocellular carcinoma to the pelvis and vertebrae in a patient with chronic hepatitis 'C' with unknown primary
S. H. Abbas,M. Z. U. I. Khan,M. Ijaz,S. J. A. Hussain
Case Reports.2015;2015(feb20 1)bcr2014207249
[DOI]
68Endometriosis and Cancer
Milena Králícková,Petr Losan,Vaclav Vetvicka
Women's Health.2014;10(6)591
[DOI]
69Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact
Mohamed Hassany,Aisha Elsharkawy,Amr Maged,Mai Mehrez,Noha Asem,Ahmed Gomaa,Zeinab Mostafa,Bahaa Abbas,Mohamad Soliman,Gamal Esmat
European Journal of Gastroenterology & Hepatology.2018;30(8)876
[DOI]
70Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections
Nicasio Mancini,Lara Marrone,Nicola Clementi,Giuseppe A Sautto,Massimo Clementi,Roberto Burioni
Future Microbiology.2015;10(4)665
[DOI]
71Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression
Bao Ngoc Nguyen,Yukiko Okuno,Masahiko Ajiro,Kei Iida,Masatsugu Denawa,Makoto Yamamoto,Naoya Sakamoto,Hiroyuki Kagechika,Masatoshi Hagiwara
Journal of Medical Virology.2017;89(7)1224
[DOI]
72Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression
Bao Ngoc Nguyen,Yukiko Okuno,Masahiko Ajiro,Kei Iida,Masatsugu Denawa,Makoto Yamamoto,Naoya Sakamoto,Hiroyuki Kagechika,Masatoshi Hagiwara
Experimental and Clinical Transplantation.2017;15(Suppl 1)1224
[DOI]
73A vitamin D protocol post-liver transplantation
Cristin Grant
Journal of the American Association of Nurse Practitioners.2017;29(11)658
[DOI]
74Epidermal growth factor, its receptor and transforming growth factor-ß1 in the diagnosis of HCV-induced hepatocellular carcinoma
Fatma Shehata,Nihad Abdel Monem,Mohamed Sakr,Samar Kasem,Mahmoud Balbaa
Medical Oncology.2013;30(3)658
[DOI]
75Successful twice interrupted therapy of HCV infection in patients with cirrhosis with hepatocellular carcinoma before and after liver transplantation
Anna Szymanek-Pasternak,Karolina Rostkowska,Krzysztof Simon
BMJ Case Reports.2017;30(3)bcr-2017-220152
[DOI]
76Chronic Hepatitis C Virus Infection is Associated with an Increased Risk of Lung Cancer: A Systematic Review and Meta-analysis
Ben Ponvilawan,Nipith Charoenngam,Pongprueth Rujirachun,Phuuwadith Wattanachayakul,Surapa Tornsatitkul,Thanitsara Rittiphairoj,Patompong Ungprasert
Lung.2020;198(4)705
[DOI]
77Host factors associated with serologic inflammatory markers assessed using multiplex assays
Heather S. McKay,Jay H. Bream,Joseph B. Margolick,Otoniel Martínez-Maza,John P. Phair,Charles R. Rinaldo,Alison G. Abraham,Lisa P. Jacobson
Cytokine.2016;85(4)71
[DOI]
78Association between Echinococcus granulosus infection and cancer risk – a pilot study in Cyprus
Katerina Oikonomopoulou,Herbert Yu,Zhanwei Wang,Stella K. Vasiliou,Davor Brinc,Georgios Christofi,Marilena Theodorou,Pavlos Pavlou,Andreas Hadjisavvas,Christiana A. Demetriou,Kyriacos Kyriacou,Eleftherios P. Diamandis
Clinical Chemistry and Laboratory Medicine (CCLM).2016;54(12)71
[DOI]
79E6AP goes viral: the role of E6AP in viral- and non-viral-related cancers
Ivona Bandilovska,Simon P Keam,Cristina Gamell,Claudia Machicado,Sue Haupt,Ygal Haupt
Carcinogenesis.2019;40(6)707
[DOI]
  Addresses 
  My Preferences 


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008